Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sonoma Pharmaceuticals, Inc.

3.60
+0.15804.59%
Volume:4.24K
Turnover:15.06K
Market Cap:6.12M
PE:-1.65
High:3.60
Open:3.46
Low:3.46
Close:3.44
52wk High:6.92
52wk Low:1.75
Shares:1.70M
Float Shares:1.62M
Volume Ratio:0.82
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1867
EPS(LYR):-2.7857
ROE:-76.14%
ROA:-14.16%
PB:1.62
PE(LYR):-1.29

Loading ...

Sonoma Pharmaceuticals to Exhibit at MEDICA in Düsseldorf

Reuters
·
Nov 07

Sonoma Pharmaceuticals Q2 revenue beats expectations on increased distributor sales

Reuters
·
Nov 04

BRIEF-Sonoma Pharmaceuticals Q2 Net Income USD -500 Thousand

Reuters
·
Nov 04

Sonoma Pharmaceuticals Q2 Gross Profit USD 2.1 Million

THOMSON REUTERS
·
Nov 04

Sonoma Pharmaceuticals Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
Nov 03

Sonoma Pharmaceuticals Inc - on Oct 18, Bruce Thornton Terminated as Executive Vice President and COO - SEC Filing

THOMSON REUTERS
·
Oct 24

Sonoma Pharmaceuticals Fires COO Bruce Thornton for Cause

Reuters
·
Oct 24

Sonoma Pharmaceuticals announces new compensation agreement for CEO Amy Trombly

Reuters
·
Oct 10

Sonoma Pharmaceuticals Secures FDA MoCRA Registration for Microcyn-Based Cosmetic Products, Expanding U.S. Market Access

Reuters
·
Oct 07

Sonoma Pharmaceuticals Inc - Enters at Market Issuance Sales Agreement With Ladenburg - SEC Filing

THOMSON REUTERS
·
Sep 27

Sonoma Pharmaceuticals Announces At-The-Market Offering of Common Stock Worth Up to $2.07 Million

Reuters
·
Sep 27

Sonoma Pharmaceuticals Inc. to Participate in Lytham Partners Fall 2025 Investor Conference

Reuters
·
Sep 26

Sonoma Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
Aug 30

Sonoma Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08

Sonoma Pharmaceuticals Q1 EPS $(0.76) Misses $(0.51) Estimate, Sales $4.015M Miss $4.050M Estimate

Benzinga
·
Aug 08

Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million

THOMSON REUTERS
·
Aug 08

Sonoma Pharmaceuticals Q1 Gross Profit USD 1.5 Million

THOMSON REUTERS
·
Aug 08

Sonoma Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview

Reuters
·
Aug 05

Sonoma Pharmaceuticals Reports 15% Decline in U.S. Revenue, 16% Growth in European Sales for Fiscal Year Ending March 31, 2025

Reuters
·
Jun 18